Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 385 Myelodysplastic Syndromes 160 Leukemia, Myelomonocytic, Chronic 76 Leukemia 65 Recurrence 32 Myeloproliferative Disorders 23 Hematologic Neoplasms 20 Neoplasms 19 Multiple Myeloma 17 Carcinoma, Non-Small-Cell Lung 17 Lymphoma, Non-Hodgkin 16 Lymphoma 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Lymphoma, Large B-Cell, Diffuse 14 Anemia, Refractory, with Excess of Blasts 14 Lymphoma, T-Cell, Peripheral 13 Primary Myelofibrosis 12 Neoplasm, Residual 12 Leukemia, Monocytic, Acute 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Leukemia, Biphenotypic, Acute 11 Leukemia, Myelomonocytic, Acute 10 Hodgkin Disease 10 Myelodysplastic-Myeloproliferative Diseases 9 Leukemia, Erythroblastic, Acute 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia, Megakaryoblastic, Acute 8 Congenital Abnormalities 8

Interventions

Temozolomide 159 Bevacizumab 69 Radiotherapy 68 Magnetic Resonance Spectroscopy 68 Irinotecan 31 Surgical Procedures, Operative 27 Radiation 24 Carboplatin 23 Specimen Handling 20 Carmustine 20 Blood Specimen Collection 20 Nivolumab 19 Aminolevulinic Acid 18 Biopsy 17 Lomustine 16 pembrolizumab 13 Radiotherapy, Intensity-Modulated 13 Cyclophosphamide 13 trametinib 12 fluorodopa F 18 12 X-Rays 12 Radiosurgery 12 Erlotinib Hydrochloride 12 Topotecan 11 Everolimus 11 Magnetic Resonance Imaging 10 IL13-PE38 10 dabrafenib 9 Etoposide 9 Drug Therapy 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Azacitidine × Clear all

NCT03666559 2024-02-29

AGIR

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡